Targeting Disseminated Estrogen-Receptor-Positive Breast Cancer Cells in Bone Marrow

Estrogen receptor-positive (ER+) breast cancer can recur up to 20 years after initial diagnosis. Delayed recurrences arise from disseminated tumors cells (DTCs) in sites such as bone marrow that remain quiescent during endocrine therapy and subsequently proliferate to produce clinically-detectable m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Buschhaus, Johanna M., Humphries, Brock A., Eckley, Samantha S., Robison, Tanner H., Cutter, Alyssa C., Rajendran, Shrila, Haley, Henry R., Bevoor, Avinash S., Luker, Kathryn E., Luker, Gary D.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442734/
https://ncbi.nlm.nih.gov/pubmed/32678295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01391-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars